首页> 外文会议>Proceedings of the 29th Annual Meeting of the Controlled Release Society >DEVELOPMENT AND EVALUATION OF MUCOADHESIVE BUCCAL TABLETS OF SECNIDAZOLE
【24h】

DEVELOPMENT AND EVALUATION OF MUCOADHESIVE BUCCAL TABLETS OF SECNIDAZOLE

机译:西地那唑微创口腔片剂的研制与评价

获取原文

摘要

The aim of the study was to develop and evaluate the muco adhesive buccal tablets of secnidazole for the treatment of oro dental infections. 100mg of tablet contained 20 mg of drug and the polymer matrix consisted of two polymers ,Carbopol 934P was used in combination with the following polymers, Hydroxy Propyl Methyl Cellulose(HPMC) K15M, Sodium Carboxy Methyl Cellulose(SCMC),Poly Vinyl Pyrrolidine(PVP) K-30,HPMC K4M and Hydroxy Propyl Cellulose-M(HPC-M).These tablets were evaluated for the in vitro release studies, bio adhesive performance. The formulation containing CP934P and SCMC was found to give the best results and hence was chosen for optimization. The optimized formulation was subjected to the in situ release studies , permeation studies, microbiological evaluation, in vivo studie and stability studies.
机译:该研究的目的是开发和评估塞尼达唑的粘膜粘膜颊粘片用于口腔内感染的治疗。 100毫克片剂含20毫克药物,聚合物基质由两种聚合物组成,Carbopol 934P与以下聚合物结合使用:羟丙基甲基纤维素(HPMC)K15M,羧甲基纤维素钠(SCMC),聚乙烯基吡咯烷酮(PVP) )K-30,HPMC K4M和羟丙基纤维素-M(HPC-M)。评估了这些片剂的体外释放研究,生物粘附性能。发现包含CP934P和SCMC的配方可提供最佳结果,因此选择进行优化。对优化的制剂进行原位释放研究,渗透研究,微生物学评估,体内研究和稳定性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号